| |
Acne
vulgaris is a chronic inflammatory disorder of the pilosebaceous
unit, the hair follicle and its associated sebaceous
glands, located on the face, chest, and back. Several
factors contribute to the pathogenesis of acne. They
include sebum, inflammation, abnormal follicular differentiation,
and Propionibacterium acnes. Acne has been reported
to cause psychological and social disability amongst
its sufferers, especially young adults.
Conventional drugs, systemic and topical antibiotics,
have been used to treat acne. However, they have side
effects that may cause problems with long-term use.
New, effective treatments suitable for long-term therapy
have been sought for Acne vulgaris.
Ayurveda is an ancient branch of medicine that has
been used for a long time in the Indian system of medicine.
It has been called the "science of life (‘Ayur’
means life and ‘Veda’ means knowledge).
Several Ayurvedic formulations have been used to treat
acne; however, their effectiveness has not been tested
in controlled clinical trials. Paranjpe et al. evaluated
4 Ayurvedic treatments for acne in a randomized, double-blind,
placebo-controlled, clinical trial.
The four Ayurvedic formulations are known in vernacular
as 1) Sookshma Triphala, 2) Thiostanin, 3) Shankhabhasma
Vati, and 4) Sunder Vati. Sookshma Triphala is comprised
of minerals and the fruits of three botanicals combined
to prepare triphala, Terminalia chebula ("Harad"),
Terminalia belerica ("Bahera"), and Emblica
officinalis ("Amla"). Thiostanin is comprised
of minerals, the fruits of T. belerica, T. chebula,
and Emblica officinalis, Commiphora mukul ("Guggul"),
nd the roots of Plumbago zeylanica, and Picrorrhiza
kurroa a ("Kutaki"). Shankhabhasma Vati consists
of conch shell, and Sunder Vati consists of Holarrhena
antidysenterica ("Kuda"), Emblica officinalis,
Embelia ribes ("Baberang"- Hindi, "Vidanga"-
Sanskrit), and Zingiber officinale ("Adrak"-
Hindi, Ginger- common name). (The names given in the
parentheses are in Hindi unless otherwise noted.) Each
formulation was prepared into 250 mg tablets for administration.
Participants of the study included eighty-two patients
(40 males and 42 females) with moderate Acne vulgaris
of the face manifested by at least 10 papules or pustules
and at least 5 open or closed comedones. (papule- small,
raised abnormality or spot on the skin.; pustule- a
small blister on the skin containing pus.; comedone-
a plug of sebum and keratin in the outlet of the skin’s
sebaceous gland that is also known as a blackhead.)
Of the 82 patients, 66 completed the study. All subjects
discontinued the use of topical and systemic acne treatments
and medications at least 2 weeks before entry into the
study. They were randomly divided into 5 groups- Sookshma
Triphala, Thiostanin, Placebo, Shankhabhasma Vati, and
Sunder Vati. None of the groups significantly differed
concerning sex, age, diet, smoking status, complexion,
use of makeup, allergies, or status of acne. Depending
on which group they belonged to, patients took two tablets
of their specified treatment three times a day with
water and after meals for a period of 6 weeks.
Every 2 weeks the subjects’ skin was evaluated
by one of the study’s investigators. The investigator
evaluated the subjects by 2 parameters: (1) the exact
number of lesion types (papular, pustular, nodulystic
lesions, and open or closed comedones) on the face from
ear to ear, (2) comparison of patient’s facial
acne after treatment with his/her initial appearance
before treatment rated on a scale from excellent to
worse.

Figure 1. Changes in inflammatory
lesions during treatment. (*p<0.01)
Of the Ayurvedic formulations, Sunder
Vati was the only formulation found to be orally effective
in the treatment of Acne vulgaris. The lesions of
the Sunder Vati group were significantly reduced.
This group also showed an excellent response to an
overall change in facial acne.

Figure 2. Changes in non-inflammatory
lesions during treatment. (*p<0.01)
Source:
Paranjpe, P. and Kulkurni, P.H. (1995) J. Ethnopharmacol.
49, 127-132.
Sabinsa Corporation supplies standardized
extracts of Terminalia belerica (min. 40% tannins),
Terminalia chebula (min. 40% tannins), Emblica officinalis
(min. 40% tannins), Triphala (combination of the first
3 standardized extracts), Embelia ribes (min. 5% embelin),
Gugulipid® (Commiphora
mukul- dry extract: min. 2.5% guggulsterones Z &
E and soft extract: min. 7.5% guggulsterones Z &
E), Picroliv® (Picrorhiza
kurroa- min. 4% kutkin and 8-10% bitter principles),
and Zingiber officinale (dry extract: min. 5% gingerols
and soft ectract: min. 20% gingerols. Powders are
also available of T. belerica, T. chebula, Triphala,
E. officinalis, and P. kurroa.
Please contact Sabinsa for information
about these products and the other products of our
nutritional, cosmeceutical, and functional food lines.
|